Gruenenthal Gmbh

Grunenthal Gmbh

Gruenethal Gmbh

Gruenthal Gmbh

Elmar Josef Friderichs

Babette-Yvonne Koegel

Werner Guenter Englberger

Klaus Schiene

Klaus Linz

Bernd Sundermann

Helmut Heinrich Buschmann

Hans Schick

Stefan Oberboersch

Helmut Sonnenschein

Claudia Hinze

Wolfgang Werner Strassburger

Birgitta Henkel

Ulrich Jahnel

Valerie Sarah Rose

Michael Jonathan Lipkin

Otto Aulenbacher

Thomas Christoph

Guenter Haase

Hagen-Heinrich Hennies

Ivars Graudums

Oswald K Zimmer

Helmut Buschmann

Wolfgang Schroeder

Norma Selve

Babette Koegel

Achim Kless

Johannes Bartholomäus

Beatrix Merla

Wolfgang Schröder

Derek John Saunders

Jean De Vry

Petra Bloms-Funke

Sven Frormann

Werner Winter

Dagmar Kaulartz

Wolfgang Werner Alfred Strassburger

Stefan Oberbörsch

Babette-Yvonne Kögel

Wolfgagn Werner Strassburger

Ernst Frankus

Murielle Meen

Guenther Haase

Babette-yvonne Kögel

Günter Haase

Muriel Meen

Jörg Holenz

Wolfgang Strassburger

Combinations of certain analgesics with COX-II inhibitors, related pharmaceutical compositions, including advantageous galenical forms containing these combinations, and the use of such combinations in methods of treatment, in particular for the treatment of pain.

Combination of selected analgesics and COX-II inhibitors

Spirocyclic cyclohexane compounds corresponding to formula I a method for producing them, pharmaceutical compositions containing them, and methods of using them.

Process or preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds

Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds

A method of treating or inhibiting, in particular, pain caused by inflammation in a mammal by administering to the mammal an effective inflammatory pain alleviating amount of a (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol compound or a physiologally acceptable salt thereof, such as the hydrochloride or citrate salt.

Method of treating pain caused by inflammation

Use of 1-phenyl-3-dimethylaminopropane compounds for the production of medicaments for treating neuropathic pain, preferably polyneuropathic pain, also preferably diabetic neuropathic pain, more preferably diabetic peripheral neuropathic pain, and furthermore preferably for treating diabetic peripheral neuropathy.

Use of 1 phenyl-3-dimethylamino-propane compounds for treating neuropathic pain

A method of treating or inhibiting, in particular, pain caused by inflammation in a mammal by administering to the mammal an effective inflammatory pain alleviating amount of a (1R,2R)-3-(2-dimethylaminomethyl-cyclohexyl)-phenol compound or a physiologically acceptable salt thereof, such as the hydrochloride or citrate salt.

Method of inhibiting inflammatory pain

Compositions containing spirocyclic cyclohexane compounds

Spirocyclic cyclohexane compounds useful in pharmaceutical compositions for use in the treatment of substance dependency.

Spirocyclic cyclohexane compounds useful to treat substance dependency

A method of treating or inhibiting, in particular, pain caused by inflammation in a mammal by administering to the mammal an effective inflammatory pain alleviating amount of a (1RS,3RS,6RS)-6-dimethyl-aminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol compound, preferably in the form of a physiologically acceptable salt, such as the hydrochloride.

Spirocyclic cyclohexane compounds

Combinations of certain analgesics with certain COX-II inhibitors, related pharmaceutical compositions, including advantageous galenical forms containing these combinations, and to the use thereof in methods of treatment, in particular for the treatment of pain.

The invention relates to a medicament containing the racemate of tramadol in a retarded form and the (+)-enantiomer of tramadol in a non-retarded form.

Tramadol-based medicament

Growing community of inventors

Stolberg, Germany

Elmar Josef Friderichs